47.40
0.45 (0.96%)
| Previous Close | 46.95 |
| Open | 47.05 |
| Volume | 1,668 |
| Avg. Volume (3M) | 4,885 |
| Market Cap | 511,441,280 |
| Price / Sales | 3.05 |
| Price / Book | 6.18 |
| 52 Weeks Range | |
| Earnings Date | 19 Aug 2025 |
| Profit Margin | 37.21% |
| Operating Margin (TTM) | 39.46% |
| Diluted EPS (TTM) | -0.580 |
| Quarterly Revenue Growth (YOY) | 81.80% |
| Quarterly Earnings Growth (YOY) | -34.90% |
| Total Debt/Equity (MRQ) | 137.87% |
| Current Ratio (MRQ) | 4.85 |
| Operating Cash Flow (TTM) | 74.36 M |
| Levered Free Cash Flow (TTM) | 48.68 M |
| Return on Assets (TTM) | 17.89% |
| Return on Equity (TTM) | 218.58% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (GB) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | BASILEA PHARMACEUTICA AG BASILE | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | 4.0 |
| Average | 1.00 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| BASILEA PHARMACEUTICA AG BASILE | 511 M | - | - | 6.18 |
| PHARMA MAR SA PHARMA MAR ORD SH | 16 B | 1.08% | 14.69 | - |
| ARROWHEAD PHARMACEUTICALS INC A | 4 B | - | - | - |
| GENUS PLC ORD 10P | 2 B | 0.01% | 81.55 | 3.61 |
| AVACTA GROUP PLC ORD 10P | 353 M | - | - | 2.35 |
| PROTHENA CORPORATION PLC PROTHE | 330 M | - | 7.53 | - |
|
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 0.25% |
| % Held by Institutions | 31.15% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |